Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: Changes from 2004 to 2008

European Journal of Heart Failure

Volumn 11, Issue 12, 2009, Pages 1143-1151

  Van Veldhuisen, Dirk J ^a   Maass, Alexander H ^a   Priori, Silvia G ^b   Stolt, Pelle ^c   Van Gelder, Isabelle C ^a   Dickstein, Kenneth ^d   Swedberg, Karl ^e  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF PAVIA   (Italy)

^c Medtronic Europe ^*  (Switzerland)

^d STAVANGER UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

CRT; Device therapy; Geographic differences; Heart failure; ICD; Implementation

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; AUSTRIA; BELGIUM; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATOR; DENMARK; DEVICE THERAPY; EUROPE; FINLAND; FRANCE; GERMANY; HEART FAILURE; HUMAN; IRELAND; ITALY; MAJOR CLINICAL STUDY; NETHERLANDS; NORWAY; PORTUGAL; PRIORITY JOURNAL; REGISTER; SPAIN; SWEDEN; SWITZERLAND; UNITED KINGDOM;

DEFIBRILLATORS, IMPLANTABLE; EUROPE; HEART FAILURE; HUMANS; PACEMAKER, ARTIFICIAL;

EID: 72949104923     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp149     Document Type: Article

References (34)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebezaa A, Nieminen M, Priori S, Swedberg K, on behalf of the Task Force for the Diagnosis Treatment of Acute, Chronic Heart Failure 2008 of the European Society of Cardiology. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008;10:933-989.
2. Jaarsma T, Van der Wal MHL, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, Sanderman R, Hoes AW, Van Gilst WH, Lok DJA, Dunselman PHJM, Tijsen JGP, Hillege HL, Van Veldhuisen DJ, for the COACH Study Group. Effect of moderate or intensive disease management program on outcome in patients with heart failure. The Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure (COACH). Arch Intern Med 2008;168:316-324.
3. Van Veldhuisen DJ, Van Gilst WH. The pharmacological management of heart failure: too many treatments? Eur J Heart Fail 2003;5:5-8.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgens SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrilla-tor Implantation Trial (MADIT) II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or implantable cardioverter-defirbrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
6. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, DiCarlo L, DeMets D, White BG, DeVriies DW, Feldman AM, for the Comparison of Medical Therapy, Pacing, Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
7. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. (Pubitemid 40517094)
8. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J, for the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey Programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003;24:464-474. (Pubitemid 36286188)
9. Van Veldhuisen DJ, Charlesworth A, Crijns HJGM, Lie KI, Hampton JR. Differences in drug treatment of chronic heart failure between European countries. Eur Heart J 1999;20:666-672.
10. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997-2004: a population-based analysis. J Gen Intern Med 2008;23(Suppl. 1):13-19.
11. Daubert JC, Leclerq C, Mabo P. There is plenty of room for cardiac resynchroni-zation therapy devices without back-up defibrillators in the electrical treatment of heart failure. J Am Coll Cardiol 2005;46:2204-2207.
12. Lam SKH, Owen A. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials. BMJ 2007;335:925.
13. McAllister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, page RL, Hlatky MA, Rowe BH. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction. A systematic review. JAMA 2007;297: 2502-2524.
14. Swedberg K, Cleland J, Cowie MR, Nieminen M, Priori SG, Tavazzi L, Van Veldhuisen DJ, Alonso-Pulpon L, Camm J, Dickstein K, Drexler H, Filippatos G, Linde C, Lopez-Sendon J, Santini M, Zannad F. Succesful treatment of heart failure with devices requires collaboration. Eur J Heart Fail 2008;10:1229-1235.
15. Abraham WT, Young JB, Wheelan K, Johnson WB, Smith AL, Brinkman P, Chang Y. Comparison of sudden cardiac death in heart failure patients with cardiac resynchronization and defibrillator therapy (CRT-D) versus CRT alone (CRT-P). (Abstract). J Card Fail 2008;14(Suppl. 1):S71.
16. Stabile G, Solimene F, Bertaglia E, La Rocca V, Accogli M, Scaccia A, Marrazzo N, Zoppo F, Turco P, Iuliano A, Shopova G, Ciardiello C, De Simone A. Long-term outcomes of CRT-PM versus CRT-D recipients. Pacing Clin Electrophysiol 2009; 32(Suppl. 1):S141-S145.
17. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C, on behalf of the REVERSE Study Group. Randomized trial of cardiac resynchronisation in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-1843.
18. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes M III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, for the MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361: 1329-1338.
19. Kiès P, Leclerq C, Bleeker GB, Crocq C, Molhoek SG, Poulain C, Van Erven L, Bootsma M, Zeppenfeld K, Van der Wall EE, Daubert JC, Schalij MJ, Bax JJ. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 2006;92:490-494.
20. Bleeker GB, Holman ER, Steendijk P, Boersma E, Van der Wall EE, Schalij MJ, Bax JJ. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006;48:2243-2250.
21. Camm J, Klein H, Nisam S. The cost of implantable defibrillators: perceptions and reality. Eur Heart J 2007;28:392-397.
22. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111-1121.
23. Salukhe TV, Dimpoulos K, Sutton R, Coats AJ, Piepoli M, Francis DP. Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications. Circulation 2004;109:1848-1853.
24. Al-Khatib SM, Sanders GD, Carlson M, Cicic A, Curtis A, Fonarow GC, Groeneveld PW, Hayes D, Heidenreich P, Mark D, Peterson E, Prystowsky EN, Sager P, Salive ME, Thomas K, Yancy CW, Zareba W, Zipes D. Preventing tomorrow's sudden death today: dissemination of effective therapy for sudden cardiac death prevention. Am Heart J 2008;156:613-622.
25. Foley PWX, Addison CE, Whinney SB, Patel K, Cunningham D, Frenneaux MP, Levya F. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines. Pacing Clin Electrophysiol 2009;32:S131-S134.
26. Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, Peterson ED, fonarow GC, for the Get with the Guidlelines Steering Committee Hospitals. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 2008;118:926-933.
27. Najafi F, Jamrozik K, Dobson AJ. Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure. Eur J Heart Fail 2009; 11:472-479.
28. The CRT Survey Sceintific Committee. European cardiac resynchronization therapy survey: rationale and design. Eur J Heart Fail 2009;11:326-330.
29. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, Van Veldhuisen DJ, Brugada J, on behalf of the Scientific Committee National Coordinators. The European cardiac resynchronization therapy survey. Eur Heart J 2009;30:2450-2460.
30. Kindermann M, Reil JC, Piekse B, Van Veldhuisen DJ, Böhm M. Heart failure with normal left ventricular ejection fraction (HFNEF): what is the evidence? Trends Cardiovasc Med 2008;18:280-292.
31. Khan NK, Goode KM, Cleland JGF, Rigby AS, Freemantle N, Eastaugh J, Clark AL, De Silva R, Calvert MJ, Swedberg K, Komajda M, Mareev V, Follath F, for the Euro-Heart Failure Survey Investigators. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail 2007;9:491-501.
32. Sulaiman HM, O'Loughlin C, Daly M, Conlon C, Ledwidge M, McCaffrey D, McDonald K. Need and evolution of need for device therapy in a community heart failure population. Eur J Heart Fail 2008;10:601-607.
33. Lee DS, Birnie D, Cameron D, Crystal E, Dorian P, Gula LJ, Healey JS, Janmohammad A, Khaykin Y, Krahn AD, LeFeuvre C, Simpson CS, Yee R, Hardy J, Slaughter PM, Chen Z, Alter DA, Laupacis A, Tu JV. Design and implementation of a population-based registry registry of Implantable Cardiover-ter Defibrillators (ICDs) in Ontario. Heart Rhythm 2008;5:1250-1256.
34. Lainščak M, Cleland JGF, Lenzen ML, Follath F, Komajda M, Swedberg K. International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail 2007;9: 292-299.